keyword
https://read.qxmd.com/read/38618895/detectable-plasma-severe-acute-respiratory-syndrome-coronavirus-2-spike-antigen-is-associated-with-poor-antibody-response-following-third-messenger-rna-vaccination-in-kidney-transplant-recipients
#21
JOURNAL ARTICLE
Andrew H Karaba, Zoe Swank, Sarah Hussain, Margaret Chahoud, Christine M Durand, Dorry L Segev, Mark A Robien, Peter S Heeger, Christian P Larsen, Aaron A R Tobian, David R Walt, William A Werbel
BACKGROUND: Kidney transplant recipients (KTRs) generate lower antibody responses to messenger RNA (mRNA)-based severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination, yet precise mechanisms for this poor response remain uncertain. One potential contributor is suboptimal spike antigen (sAg) translation and expression owing to transplant immunosuppression, which might lead to insufficient exposure to develop humoral and/or cellular immune responses. METHODS: Within a single-arm clinical trial, 65 KTRs underwent ultrasensitive plasma sAg testing before, and 3 and 14 days after, the third mRNA vaccine doses...
April 15, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38617298/mapping-immunodominant-sites-on-the-mers-cov-spike-glycoprotein-targeted-by-infection-elicited-antibodies-in-humans
#22
Amin Addetia, Cameron Stewart, Albert J Seo, Kaitlin R Sprouse, Ayed Y Asiri, Maha Al-Mozaini, Ziad A Memish, Abeer Alshukairi, David Veesler
Middle-East respiratory syndrome coronavirus (MERS-CoV) first emerged in 2012 and causes human infections in endemic regions. Most vaccines and therapeutics in development against MERS-CoV focus on the spike (S) glycoprotein to prevent viral entry into target cells. These efforts, however, are limited by a poor understanding of antibody responses elicited by infection along with their durability, fine specificity and contribution of distinct S antigenic sites to neutralization. To address this knowledge gap, we analyzed S-directed binding and neutralizing antibody titers in plasma collected from individuals infected with MERS-CoV in 2017-2019 (prior to the COVID-19 pandemic)...
April 2, 2024: bioRxiv
https://read.qxmd.com/read/38617283/predicting-functional-conformational-ensembles-and-binding-mechanisms-of-convergent-evolution-for-sars-cov-2-spike-omicron-variants-using-alphafold2-sequence-scanning-adaptations-and-molecular-dynamics-simulations
#23
Nishank Raisinghani, Mohammed Alshahrani, Grace Gupta, Sian Xiao, Peng Tao, Gennady Verkhivker
In this study, we combined AlphaFold-based approaches for atomistic modeling of multiple protein states and microsecond molecular simulations to accurately characterize conformational ensembles and binding mechanisms of convergent evolution for the SARS-CoV-2 Spike Omicron variants BA.1, BA.2, BA.2.75, BA.3, BA.4/BA.5 and BQ.1.1. We employed and validated several different adaptations of the AlphaFold methodology for modeling of conformational ensembles including the introduced randomized full sequence scanning for manipulation of sequence variations to systematically explore conformational dynamics of Omicron Spike protein complexes with the ACE2 receptor...
April 3, 2024: bioRxiv
https://read.qxmd.com/read/38615227/evaluation-of-sars-cov-2-humoral-response-following-vaccination-with-chadox1-ncov-19-covishield%C3%A2-and-or-sinopharm-bbibp-corv-vero-cell%C3%A2
#24
JOURNAL ARTICLE
Sher Bahadur Kamar, Hemraj Pandey, Ramesh Shahi, Shurehraman Puri, Gopal Kumar Yadav, Kapil Amgain
BACKGROUND: Billions of doses of COVID-19 vaccine have been introducing in the world to prevent pandemic COVID-19. Higher efficacy but limited data are available for its longevity. We aimed to find out the IgG Anti-SARS Cov-2 antibody level among frontline healthcare workers after two doses of vaccines. METHODS: A cross-sectional study was carried among 170 HCPs of Seti Provincial Hospital of western Nepal, who were more than 18 years, and had taken two doses of either one of COVID 19 vaccine...
March 22, 2024: Journal of Nepal Health Research Council
https://read.qxmd.com/read/38614915/molecular-and-clinical-profile-of-rare-bleeding-disorders-a-single-center-retrospective-study
#25
JOURNAL ARTICLE
Arash Ahmadfard Moghadam, Amir Reza Manafzadeh, Mohammad Reza Nikoonia, Khadijeh Dajliry, Farahnaz Ramezan, Shadi Tabibian
INTRODUCTION: Due to their low frequency, there is little information on the molecular pathologies of rare bleeding disorders (RBD). Therefore, this study aimed to analyze the molecular and clinical profiles of patients with RBD. METHODS: A retrospective single-center study was conducted among patients with factor (F) II, FVII, FX, and FXIII deficiencies between March 20, 2000, and June 31, 2023. Data on patient demographics, genetic analysis, and laboratory results were documented for all patients...
April 1, 2024: Transfusion and Apheresis Science
https://read.qxmd.com/read/38612753/design-and-escherichia-coli-expression-of-a-natively-folded-multi-disulfide-bonded-influenza-h1n1-pr8-receptor-binding-domain-rbd
#26
JOURNAL ARTICLE
Thao Tu, Tharangani Rathnayaka, Toshiyo Kato, Kenji Mizutani, Tomonori Saotome, Keiichi Noguchi, Shun-Ichi Kidokoro, Yutaka Kuroda
Refolding multi-disulfide bonded proteins expressed in E. coli into their native structure is challenging. Nevertheless, because of its cost-effectiveness, handiness, and versatility, the E. coli expression of viral envelope proteins, such as the RBD (Receptor-Binding Domain) of the influenza Hemagglutinin protein, could significantly advance research on viral infections. Here, we show that H1N1-PR8-RBD (27 kDa, containing four cysteines forming two disulfide bonds) expressed in E. coli and was purified with nickel affinity chromatography, and reversed-phase HPLC was successfully refolded into its native structure, as assessed with several biophysical and biochemical techniques...
April 1, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38608435/adjuvant-free-parenterally-injectable-vaccine-platform-that-harnesses-previously-induced-igg-as-an-antigen-delivery-carrier
#27
JOURNAL ARTICLE
Atsushi Kawai, Haruki Hirata, Nagisa Tokunoh, Chikako Ono, Yoshiharu Matsuura, Toshiro Hirai, Yasuo Yoshioka
Subunit vaccines are among the most useful vaccine modalities; however, their low immunogenicity necessitates the addition of adjuvants. Although adjuvants improve immune responses induced by vaccines, they often cause adverse reactions. To address this, we developed an adjuvant-free subunit vaccine platform that uses pre-existing antibodies generated from past infections or vaccinations as carriers for the delivery of vaccine antigens. Although we have confirmed the usefulness of this platform for nasal vaccines, its suitability as a parenterally injectable vaccine remains uncertain...
April 7, 2024: Biochemical and Biophysical Research Communications
https://read.qxmd.com/read/38604075/antigen-functionalized-turnip-mosaic-virus-nanoparticles-increase-antibody-sensing-in-saliva-a-case-study-with-sars-cov-2-rbd
#28
JOURNAL ARTICLE
Carlos Medrano-Arranz, Sara Rincón, Lucía Zurita, Fernando Ponz, Daniel A Truchado
Nanoparticles derived from plant viruses play an important role in nanomedicine due to their biocompatibility, self-assembly and easily-modifiable surface. In this study, we developed a novel platform for increasing antibody sensing using viral nanoparticles derived from turnip mosaic virus (TuMV) functionalized with SARS-CoV-2 receptor binding domain (RBD) through three different methods: chemical conjugation, gene fusion and the SpyTag/SpyCatcher technology. Even though gene fusion turned out to be unsuccessful, the other two constructs were proven to significantly increase antibody sensing when tested with saliva of patients with different infection and vaccination status to SARS-CoV-2...
April 7, 2024: Diagnostic Microbiology and Infectious Disease
https://read.qxmd.com/read/38601739/sars-cov-2-specific-mucosal-immune-response-in-vaccinated-versus-infected-children
#29
JOURNAL ARTICLE
Maria Giulia Conti, Eva Piano Mortari, Raffaella Nenna, Alessandra Pierangeli, Leonardo Sorrentino, Federica Frasca, Laura Petrarca, Enrica Mancino, Greta Di Mattia, Luigi Matera, Matteo Fracella, Christian Albano, Carolina Scagnolari, Martina Capponi, Bianca Cinicola, Rita Carsetti, Fabio Midulla
The anti-COVID-19 intramuscular vaccination induces a strong systemic but a weak mucosal immune response in adults. Little is known about the mucosal immune response in children infected or vaccinated against SARS-CoV-2. We found that 28% of children had detectable salivary IgA against SARS-CoV-2 even before vaccination, suggesting that, in children, SARS-CoV-2 infection may be undiagnosed. After vaccination, only receptor-binding domain (RBD)-specific IgA1 significantly increased in the saliva. Conversely, infected children had significantly higher salivary RBD-IgA2 compared to IgA1, indicating that infection more than vaccination induces a specific mucosal immune response in children...
2024: Frontiers in Cellular and Infection Microbiology
https://read.qxmd.com/read/38601337/associations-between-the-burdens-of-comorbid-sleep-problems-central-sensitization-and-headache-related-disability-in-patients-with-migraine
#30
JOURNAL ARTICLE
Keisuke Suzuki, Shiho Suzuki, Yasuo Haruyama, Kei Funakoshi, Hiroaki Fujita, Hirotaka Sakuramoto, Mai Hamaguchi, Gen Kobashi, Koichi Hirata
OBJECTIVE: Sleep disturbances are common in migraine patients and affect quality of life. Central sensitization (CS) is likely to play a role in the increased severity and chronicity of migraine. We hypothesized that the number of comorbid sleep problems would affect headache-related disability through the effects of central sensitization (CS). METHODS: We performed a cross-sectional study including 215 consecutive patients with migraine. Insomnia was defined as a Pittsburgh Sleep Quality Index (PSQI) global score greater than 5...
2024: Frontiers in Neurology
https://read.qxmd.com/read/38599653/incidence-and-outcome-of-covid-19-following-vaccine-and-hybrid-immunity-in-patients-on-immunosuppressive-therapy-identification-of-protective-post-immunisation-anti-rbd-antibody-levels-in-a-prospective-cohort-study
#31
JOURNAL ARTICLE
Hilde S Ørbo, Kristin H Bjørlykke, Joseph Sexton, Ingrid Jyssum, Anne T Tveter, Ingrid E Christensen, Siri Mjaaland, Tore K Kvien, Gunnveig Grødeland, Grete B Kro, Jørgen Jahnsen, Espen A Haavardsholm, Ludvig A Munthe, Sella A Provan, John T Vaage, Guro Løvik Goll, Kristin Kaasen Jørgensen, Silje Watterdal Syversen
OBJECTIVES: To assess incidence, severity and predictors of COVID-19, including protective post-vaccination levels of antibodies to the receptor-binding domain of SARS-CoV-2 spike protein (anti-RBD), informing further vaccine strategies for patients with immune-mediated inflammatory diseases (IMIDs) on immunosuppressive medication. METHODS: IMIDs on immunosuppressives and healthy controls (HC) receiving SARS-CoV-2 vaccines were included in this prospective observational study...
April 9, 2024: RMD Open
https://read.qxmd.com/read/38591877/molecular-basis-of-hippopotamus-ace2-binding-to-sars-cov-2
#32
JOURNAL ARTICLE
Ruirui Yang, Pu Han, Pengcheng Han, Dedong Li, Runchu Zhao, Sheng Niu, Kefang Liu, Shihua Li, Wen-Xia Tian, George Fu Gao
UNLABELLED: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has a wide range of hosts, including hippopotami, which are semi-aquatic mammals and phylogenetically closely related to Cetacea. In this study, we characterized the binding properties of hippopotamus angiotensin-converting enzyme 2 (hiACE2) to the spike (S) protein receptor binding domains (RBDs) of the SARS-CoV-2 prototype (PT) and variants of concern (VOCs). Furthermore, the cryo-electron microscopy (cryo-EM) structure of the SARS-CoV-2 PT S protein complexed with hiACE2 was resolved...
April 9, 2024: Journal of Virology
https://read.qxmd.com/read/38591159/evaluating-mabs-binding-abilities-to-omicron-subvariant-rbds-implications-for-selecting-effective-mab-therapies
#33
JOURNAL ARTICLE
Song Luo, Danyang Xiong, Bolin Tang, Bangyu Liu, Xiaoyu Zhao, Lili Duan
The ongoing evolution of the Omicron lineage of SARS-CoV-2 has led to the emergence of subvariants that pose challenges to antibody neutralization. Understanding the binding dynamics between the receptor-binding domains (RBD) of these subvariants spike and monoclonal antibodies (mAbs) is pivotal for elucidating the mechanisms of immune escape and for advancing the development of therapeutic antibodies. This study focused on the RBD regions of Omicron subvariants BA.2, BA.5, BF.7, and XBB.1.5, employing molecular dynamics simulations to unravel their binding mechanisms with a panel of six mAbs, and subsequently analyzing the origins of immune escape from energetic and structural perspectives...
April 9, 2024: Physical Chemistry Chemical Physics: PCCP
https://read.qxmd.com/read/38589848/expression-of-the-sars-cov-2-receptor-binding-domain-by-live-attenuated-influenza-vaccine-virus-as-a-strategy-for-designing-a-bivalent-vaccine-against-covid-19-and-influenza
#34
JOURNAL ARTICLE
Ekaterina Stepanova, Irina Isakova-Sivak, Daria Mezhenskaya, Sergei Niskanen, Victoria Matyushenko, Ekaterina Bazhenova, Alexandra Rak, Pei Fong Wong, Polina Prokopenko, Tatiana Kotomina, Elena Krutikova, Sergei Legotskiy, Bogdan Neterebskii, Tatiana Ostroukhova, Konstantin Sivak, Yana Orshanskaya, Kirill Yakovlev, Larisa Rudenko
Influenza and SARS-CoV-2 are two major respiratory pathogens that cocirculate in humans and cause serious illness with the potential to exacerbate disease in the event of co-infection. To develop a bivalent vaccine, capable of protecting against both infections, we inserted the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein into hemagglutinin (HA) molecule or into the open reading frame of the truncated nonstructural protein 1 (NS1) of live attenuated influenza vaccine (LAIV) virus and assessed phenotypic characteristics of the rescued LAIV-RBD viruses, as well as their immunogenicity in mouse and Syrian hamster animal models...
April 9, 2024: Virology Journal
https://read.qxmd.com/read/38589016/%C3%AE-synuclein-a-promising-biomarker-for-parkinson-s-disease-and-related-disorders
#35
JOURNAL ARTICLE
Taku Hatano, Ayami Okuzumi, Gen Matsumoto, Tsunemi Taiji, Nobutaka Hattori
Mutations in the SNCA gene, which encodes α-synuclein (α-syn), play a key role in the development of genetic Parkinson's disease (PD). α-Syn is a major component of Lewy bodies in PD and glial cytoplasmic inclusions in multiple system atrophy (MSA). Rapid eye movement sleep behavior disorder (RBD) patients often progress to PD, dementia with Lewy bodies (DLB), or MSA, collectively known as α-synucleinopathies. The loss of dopaminergic neurons with Lewy bodies precedes motor dysfunction in these diseases, but the mechanisms of neurodegeneration due to α-syn aggregation are poorly understood...
April 9, 2024: Journal of Movement Disorders
https://read.qxmd.com/read/38586895/alpha-synuclein-pathology-in-isolated-rapid-eye-movement-sleep-behaviour-disorder-a-meta-analysis
#36
REVIEW
Imran H Iftikhar, Sohaila AlShimemeri, Hussein Rabah, Saad Tauheed Rao, Ahmed S BaHammam
Accumulating evidence indicates that patients with isolated rapid eye movement sleep behaviour disorder (iRBD), a prodromal stage of synucleinopathies, show abnormal deposition of misfolded alpha-synuclein (a-Syn) in peripheral tissues. The clinical utility of testing for a-Syn in iRBD is unclear. This meta-analysis focused on the utility of testing for the abnormal a-Syn phosphorylated at Ser129 (p-syn) and a-Syn seeding activity (a-Syn seed amplification assays [aSyn-SAA]). Following an electronic database search, 15 studies were included that provided at a minimum data on test positivity in participants with iRBD...
April 8, 2024: Journal of Sleep Research
https://read.qxmd.com/read/38586774/boosting-vaccine-response-in-autoimmune-rheumatic-disease-patients-with-inadequate-seroconversion-an-analysis-of-the-immunogenicity-of-vector-based-and-inactivated-vaccines
#37
JOURNAL ARTICLE
Anuroopa Vijayan, Aswathy Sukumaran, Sara Jones, Aby Paul, Sakir Ahmed, Pankti Mehta, Manju Mohanan, Santhosh Kumar, Sreekumar Easwaran, Padmanabha Shenoy
BACKGROUND: An additional dose of COVID-19 vaccine is being offered to vaccinated people, especially those immunocompromised. The most widely available vaccines in India are the adenoviral vector-based AZD1222 (ChAdOx1 nCoV-19) and the heat-inactivated (BBV152). This study investigated the efficacy of both vaccines in patients with autoimmune rheumatic diseases (AIRD). OBJECTIVES:  To compare final anti-SARS-CoV-2 antibody titers, neutralization of pseudovirions by these antibodies, and T cell responses between patients of AIRD who had received the third dose of AZD1222 and BBV152 vaccines...
March 2024: Curēus
https://read.qxmd.com/read/38586111/efficacy-of-the-combination-of-brii-196-brii-198-in-the-treatment-of-covid-19-vaccine-breakthrough-infections
#38
JOURNAL ARTICLE
Xiao-Ling Guo, Kun Wang, Jie Jin, Li-Li Dai
BACKGROUND: BRII-196 and BRII-198 are two recombinant human immunoglobulin (Ig) G1 monoclonal antibodies (mAbs) that non-competitively target distinct epitope regions within the receptor-binding domain (RBD) of the coronavirus spike glycoproteins. These antibodies are derived directly from human B cells of individuals who recovered from COVID-19. OBJECTIVE: To analyze the efficacy of BRII-196/BRII-198 in the treatment of coronavirus disease 2019 (COVID-19) vaccine breakthrough infections...
2024: American Journal of Translational Research
https://read.qxmd.com/read/38583808/insertion-of-foreign-genes-into-the-simian-varicella-virus-genome-by-tn7-mediated-site-specific-transposition
#39
JOURNAL ARTICLE
Wayne L Gray
A Tn7-transposition approach was utilized for site-specific insertion of foreign genes into the genome of simian varicella virus (SVV), the causative agent of simian varicella in nonhuman primates. The severe acute respiratory syndrome coronavirus (SARS-CoV-2) nucleocapsid (N) gene and receptor binding domain (RBD) of the spike gene were inserted into the ORF 14 region of the SVV genome cloned into a bacterial artificial chromosome and then transfected into Vero cells to generate the infectious recombinant SVV (rSVV)...
April 5, 2024: Journal of Virological Methods
https://read.qxmd.com/read/38577029/immune-responses-in-discharged-covid-19-patients-with-and-without-long-covid-symptoms
#40
JOURNAL ARTICLE
Yeming Wang, Li Guo, Dan Cui, Hui Zhang, Qiao Zhang, Lili Ren, Geng Wang, Xueyang Zhang, Tingxuan Huang, Lan Chen, Lixue Huang, Xinming Wang, Jinchuan Zhong, Ying Wang, Hui Li, Jianwei Wang, Bin Cao
The immune mechanisms of long coronavirus disease 2019 (COVID) are not yet fully understood. We aimed to investigate the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific memory immune responses in discharged COVID-19 patients with and without long COVID symptoms. In this cross-sectional study, we included 1041 hospitalized COVID-19 patients with the original virus strain in Wuhan (China) 12 months after initial infection. We simultaneously conducted a questionnaire survey and collected peripheral blood samples from the participants...
April 2024: Open Forum Infectious Diseases
keyword
keyword
12131
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.